These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37854455)

  • 1. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.
    Walborn AT; Heath A; Neal MD; Zarychanski R; Kornblith LZ; Hunt BJ; Castellucci LA; Hochman JS; Lawler PR; Paul JD
    Res Pract Thromb Haemost; 2023 Oct; 7(7):102203. PubMed ID: 37854455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    ; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19.
    Cullivan S; Sholzberg M; Áinle FN; Kevane B
    Thromb Update; 2022 Mar; 6():100097. PubMed ID: 38620689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    ; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
    Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
    Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
    Smilowitz NR; Hade EM; Kornblith LZ; Castellucci LA; Cushman M; Farkouh M; Gong MN; Heath A; Hunt BJ; Kim KS; Kindzelski A; Lawler P; Leaf DE; Goligher E; Leifer ES; McVerry BJ; Reynolds HR; Zarychanski R; Hochman JS; Neal MD; Berger JS
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102167. PubMed ID: 37727846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Goligher EC; Lawler PR; Jensen TP; Talisa V; Berry LR; Lorenzi E; McVerry BJ; Chang CH; Leifer E; Bradbury C; Berger J; Hunt BJ; Castellucci LA; Kornblith LZ; Gordon AC; McArthur C; Webb S; Hochman J; Neal MD; Zarychanski R; Berry S; Angus DC;
    JAMA; 2023 Apr; 329(13):1066-1077. PubMed ID: 36942550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.
    Godoy LC; Neal MD; Goligher EC; Cushman M; Houston BL; Bradbury CA; McQuilten ZK; Tritschler T; Kahn SR; Berry LR; Lorenzi E; Jensen T; Higgins AM; Kornblith LZ; Berger JS; Gong MN; Paul JD; Castellucci LA; Le Gal G; Lother SA; Rosenson RS; Derde LPG; Kumar A; McVerry BJ; Nicolau JC; Leifer E; Escobedo J; Huang DT; Reynolds HR; Carrier M; Kim KS; Hunt BJ; Slutsky AS; Turgeon AF; Webb SA; McArthur CJ; Farkouh ME; Hochman JS; Zarychanski R; Lawler PR
    JACC Adv; 2024 Mar; 3(3):100780. PubMed ID: 38938844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.
    Pilia E; Belletti A; Fresilli S; Finco G; Landoni G
    J Thromb Thrombolysis; 2022 Oct; 54(3):420-430. PubMed ID: 35922578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
    Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trials of therapeutic heparin for COVID-19: A meta-analysis.
    Sholzberg M; da Costa BR; Tang GH; Rahhal H; AlHamzah M; Baumann Kreuziger L; Ní Áinle F; Almarshoodi MO; James PD; Lillicrap D; Carrier M; Beckett A; Fralick M; Middeldorp S; Lee AYY; Thorpe KE; Negri EM; Cushman M; Jüni P;
    Res Pract Thromb Haemost; 2021 Dec; 5(8):e12638. PubMed ID: 34977448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis.
    Millet C; Narvaneni S; Shafeek F; Roman S; Mechineni A; Manickam R
    Cureus; 2022 Feb; 14(2):e22061. PubMed ID: 35340525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
    Berger JS; Neal MD; Kornblith LZ; Gong MN; Reynolds HR; Cushman M; Althouse AD; Lawler PR; McVerry BJ; Kim KS; Baumann Kreuziger L; Solomon SD; Kosiborod MN; Berry SM; Bochicchio GV; Contoli M; Farkouh ME; Froess JD; Gandotra S; Greenstein Y; Hade EM; Hanna N; Hudock K; Hyzy RC; Ibáñez Estéllez F; Iovine N; Khanna AK; Khatri P; Kirwan BA; Kutcher ME; Leifer E; Lim G; Lopes RD; Lopez-Sendon JL; Luther JF; Nigro Maia L; Quigley JG; Wahid L; Wilson JG; Zarychanski R; Kindzelski A; Geraci MW; Hochman JS;
    JAMA Netw Open; 2023 May; 6(5):e2314428. PubMed ID: 37227729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial.
    Blondon M; Cereghetti S; Pugin J; Marti C; Darbellay Farhoumand P; Reny JL; Calmy A; Combescure C; Mazzolai L; Pantet O; Ltaief Z; Méan M; Manzocchi Besson S; Jeanneret S; Stricker H; Robert-Ebadi H; Fontana P; Righini M; Casini A
    Res Pract Thromb Haemost; 2022 May; 6(4):e12712. PubMed ID: 35599701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Therapeutic Anticoagulation in COVID-19: The Current Situation.
    Rahi MS; Parekh J; Pednekar P; Mudgal M; Jindal V; Gunasekaran K
    Hematol Rep; 2023 Jun; 15(2):358-369. PubMed ID: 37367086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.
    Zhang S; Li Y; Liu G; Su B
    Thromb J; 2021 Nov; 19(1):91. PubMed ID: 34819094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.